Xilio Development Inc (XLO)

Xilio Development Inc (XLO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $58.6M; returns 1 day -5.7%, 1 week -11.5%, 1 year -30.0%.

Xilio Therapeutics, Inc. (XLO) is a clinical-stage biotechnology company focused on the discovery and development of tumor-activated immuno-oncology (I-O) therapies for people living with cancer.

Groups XLO belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Clinical Stage
• Healthcare
• Life Sciences
• Antibody Therapeutics
• Precision Medicine

XLO financial model: income statement, cash flow and balance sheet